| 标题 |
Trastuzumab deruxtecan in hormone receptor-positive, HER2-low/-ultralow metastatic breast cancer (DESTINY-Breast06): outcome analyses by time to progression on prior first-line endocrine therapy with CDK4/6 inhibitor and baseline burden of disease |
| 网址 | |
| DOI | |
| 其它 |
期刊:Annals of Oncology 作者:G. Curigliano; X Hu; R. Dent; K. Yonemori; CH Barrios; et al 出版日期:2026-03-02 |
| 求助人 | |
| 下载 | 该求助完结已超 24 小时,文件已从服务器自动删除,无法下载。 |
PDF的下载单位、IP信息已删除
(2025-6-4)